Israeli Pharma Giant Teva wins FDA approval for monthly schizophrenia injection Weltruza
Posted
Weltruza is Teva's second U.S.-approved product made in partnership with French biotech company Medincell. It uses long-acting injectable technology, designed to release medication over an extended period
published by
